SCHEMBL4909548

SCHEMBL4909548

CCN(Oc1ccc(OCc2ccccc2)cc1)S(=O)(=O)c1ccc(C)c(C(=O)OC)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP9 P14780 6/20 0.48
MMP13 P45452 6/20 0.48
ADAM17 P78536 6/20 0.48
MMP2 P08253 4/20 0.48
CA1 P00915 2/20 0.48
CA2 P00918 2/20 0.48
CA9 Q16790 2/20 0.48
MMP14 P50281 3/20 0.43
MMP1 P03956 3/20 0.43
ADAMTS4 O75173 2/20 0.43
ADAMTS5 Q9UNA0 2/20 0.43
PKM P14618 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
ALDH1A1 P00352 4/20 0.43
TSHR P16473 1/20 0.43
KEAP1 Q14145 1/20 0.42
AR P10275 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
NOX1 Q9Y5S8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4895518 0.91 MMP9 (0.48) MMP9MMP13ADAM17MMP2CA1
SCHEMBL4906721 0.88 ALDH1A1 (0.46) MMP9MMP13ADAM17MMP2CA1
SCHEMBL4905129 0.86 MMP13 (0.52) MMP9MMP13ADAM17MMP1ALDH1A1
SCHEMBL4902618 0.82 ALDH1A1 (0.46) MMP9MMP13MEN1KMT2AALDH1A1
SCHEMBL4895626 0.80 TAS2R14 (0.56) MMP9MMP13ADAM17MMP2CA1
SCHEMBL4903045 0.79 ALDH1A1 (0.53) MEN1KMT2AALDH1A1TSHRNPC1
SCHEMBL4909535 0.79 TDP1 (0.57) MMP9MMP13ADAM17MMP2CA1
SCHEMBL4902970 0.78 KEAP1 (0.48) MMP9MMP13ADAM17PKMKMT2A
SCHEMBL4899843 0.78 LMNA (0.44) MMP9MMP13ADAM17MMP2MMP14
SCHEMBL4905124 0.78 ALDH1A1 (0.55) MMP9MMP13ADAM17MMP2MMP14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD MMP9 4666/4885MMP13 3379/4885ADAM17 4821/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD MMP9 4632/4885MMP13 3079/4885ADAM17 4813/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.